|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Accounts receivable: | ||||||||||||||||||||
| Trade | ||||||||||||||||||||
| Other, net | ||||||||||||||||||||
| Inventories: | ||||||||||||||||||||
| Concentrates, dore, stockpiled ore, and metals in transit and in-process | ||||||||||||||||||||
| Product inventories | ||||||||||||||||||||
| Materials and supplies | ||||||||||||||||||||
| Current investments | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Investments | ||||||||||||||||||||
| Non-current investments | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Property, plants, equipment and mine development, net | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Deferred tax assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued payroll and related benefits | ||||||||||||||||||||
| Accrued taxes | ||||||||||||||||||||
| Current debt | ||||||||||||||||||||
| Finance leases | ||||||||||||||||||||
| Accrued reclamation and closure costs | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating leases | ||||||||||||||||||||
| Finance leases | ||||||||||||||||||||
| Operating leases | ||||||||||||||||||||
| Accrued reclamation and closure costs | ||||||||||||||||||||
| Long-term debt including finance leases | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Pension liability | ||||||||||||||||||||
| Derivatives liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Liabilities of discontinued operations | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| STOCKHOLDERS' EQUITY | ||||||||||||||||||||
| Series B preferred stock, $0.25 par value, 151,003 shares issued and outstanding, liquidation preference - $7,550 | ||||||||||||||||||||
| Total series B preferred stock, $0.25 par value, 151,003 shares issued and outstanding, liquidation preference - $7,550 | ||||||||||||||||||||
| Common stock, $0.25 par value, authorized 1,250,000,000 shares; issued June 30, 2026 - 680,917,122 shares and December 31, 2025 - 679,220,408 shares | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Less treasury stock, at cost; June 30, 2026 - 8,967,482 and December 31, 2025 - 8,920,348 shares issued and held in treasury | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
